This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: Northwest Biotherapeutics, Inc.. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2013
Title: Innovations by Allen Turner in Leukocyte Enrichment
Introduction
Allen Turner is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of biotherapeutics, particularly in the development of devices for leukocyte enrichment. With a total of two patents to his name, Turner is recognized for his innovative approaches to enhancing blood constituent separation.
Latest Patents
Turner's latest patents focus on tangential flow filtration devices and methods for leukocyte enrichment. The inventions provide a means to enrich a heterogeneous mixture of blood constituents for leukocytes by effectively removing non-leukocyte blood constituents. One embodiment of the device includes a remover unit featuring a crossflow chamber separated by a microporous filter from a filtrate chamber. This design allows for a tangential flow inlet, a fluid outlet for leukocyte-enriched fluid, and a filtrate outlet. The technology aims to provide a composition enriched in monocytes, which can be crucial for various medical applications.
Career Highlights
Allen Turner is currently associated with Northwest Biotherapeutics, Inc., where he continues to innovate in the field of biotherapeutics. His work has been instrumental in advancing methods that improve the efficiency of leukocyte separation, which is vital for research and therapeutic purposes.
Collaborations
Turner collaborates with notable colleagues, including Marnix L Bosch and Paul C Harris. Their combined expertise contributes to the ongoing development of innovative solutions in the biotherapeutics sector.
Conclusion
Allen Turner's contributions to the field of leukocyte enrichment through his patented inventions demonstrate his commitment to advancing medical technology. His work at Northwest Biotherapeutics, Inc. continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
